- Home
- AVGR vs INM Comparison
AVGR vs INM Comparison
Compare AVGR & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVGR
- INM
- Stock Information
- Founded
- AVGR 2007
- INM 1981
- Country
- AVGR United States
- INM Canada
- Employees
- AVGR N/A
- INM N/A
- Industry
- AVGR Medical/Dental Instruments
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- AVGR Health Care
- INM Health Care
- Exchange
- AVGR Nasdaq
- INM Nasdaq
- Market Cap
- AVGR 2.6M
- INM 3.0M
- IPO Year
- AVGR 2015
- INM N/A
- Fundamental
- Price
- AVGR $0.56
- INM $3.12
- Analyst Decision
- AVGR Strong Buy
- INM
- Analyst Count
- AVGR 1
- INM 0
- Target Price
- AVGR $5.00
- INM N/A
- AVG Volume (30 Days)
- AVGR 877.5K
- INM 1.4M
- Earning Date
- AVGR 03-19-2025
- INM 02-14-2025
- Dividend Yield
- AVGR N/A
- INM N/A
- EPS Growth
- AVGR N/A
- INM N/A
- EPS
- AVGR N/A
- INM N/A
- Revenue
- AVGR $7,262,000.00
- INM $4,960,506.00
- Revenue This Year
- AVGR N/A
- INM N/A
- Revenue Next Year
- AVGR $93.49
- INM N/A
- P/E Ratio
- AVGR N/A
- INM N/A
- Revenue Growth
- AVGR N/A
- INM 5.17
- 52 Week Low
- AVGR $0.39
- INM $2.42
- 52 Week High
- AVGR $5.45
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- AVGR 43.82
- INM 30.59
- Support Level
- AVGR $0.50
- INM $2.86
- Resistance Level
- AVGR $0.65
- INM $8.27
- Average True Range (ATR)
- AVGR 0.06
- INM 0.64
- MACD
- AVGR 0.00
- INM -0.14
- Stochastic Oscillator
- AVGR 32.90
- INM 3.88
About AVGR Avinger Inc.
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.